Improving Aspirin Prescription Rates in Outpatient Clinic

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-01

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ρrееςlаmpѕia is a syndrome characterised by the new onset of hуреrtеnѕion plus proteinuria, end-organ dysfunction, or both after 20 weeks of gestation. It complicates 3-5% of pregnancies.

Low-dose aspirin reduces the frequency of рrееςlampsia, as well as related adverse рrеgոaոcy outcomes (preterm birth, growth restriction), by 10 to 70% when taken by patients аt moderate to high risk of the disease. It has an excellent maternal/fetal safety profile. Thus, it is a reasonable preventive strategy for these patients.

A pilot study at our hospital found that not all patients who are candidates for aspirin prescription receive it (only 40%). This audit cycle aims to increase aspirin prescription rates for moderate and high-risk obstetric populations.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Low Dose Aspirin for Prevention of Early Pregnancy Loss

NCT06261203

Pre-Eclampsia

RECRUITING NA

Aspirin Role for Preventing Clinical Risks Related to High Risk Pregnancy

NCT07087067

Preeclampsia Pregnancy

COMPLETED NA

Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)

NCT04402385

Pre-Eclampsia Stage 1 Hypertension Elevated Blood Pressure

TERMINATED PHASE2

The Effectiveness of Aspirin on Preventing Pre-eclampsia

NCT04656665

Pre-Eclampsia

UNKNOWN PHASE4

Low Doses of Aspirin in the Prevention of Preeclampsia

NCT04070573

Preeclampsia

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Birth Weight Small for Gestational Age (SGA) Preeclampsia (PE) Prevention &Amp; Control

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Obstetric population candidate for aspirin prescription

Moderate- and high-risk obstetric population

Aspirin prescription on outpatient basis

Intervention Type OTHER

Improving aspirin prescription rates for candidate patients (moderate- and high-risk obstetric population)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aspirin prescription on outpatient basis

Improving aspirin prescription rates for candidate patients (moderate- and high-risk obstetric population)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Women at high risk are those with any of the following:

1. hypertensive disease during a previous pregnancy
2. chronic kidney disease
3. autoimmune disease such as systemic lupus erythematosus or antiphospholipid syndrome
4. type 1 or type 2 diabetes
5. chronic hypertension.

Women with more than one moderate risk factor, such as are:

1. nulliparity
2. age 40 years or older
3. pregnancy interval of more than 10 years
4. body mass index (BMI) of 35 kg/m2 or more at first visit
5. family history of pre-eclampsia
6. multi-fetal pregnancy.